Sign Up to like & get
recommendations!
0
Published in 2019 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofz360.892
Abstract: Abstract Background Dalbavancin is a lipoglycopeptide antibiotic active against Gram-positive organisms with an extended half-life that allows for weekly dosing. Initially approved for treating skin and soft-tissue infections, use for more complicated infections provides several…
read more here.
Keywords:
complicated infections;
dalbavancin use;
dalbavancin;
cost ... See more keywords